AAV serotype 8-mediated liver specific GNMT expression delays progression of hepatocellular carcinoma and prevents carbon tetrachloride-induced liver damage.

AAV serotype 8-mediated liver specific GNMT expression delays progression of hepatocellular carcinoma and prevents carbon tetrachloride-induced liver damage.
复制标题

DOI:
10.1038/s41598-018-30800-3
复制
发表时间:
2018-09-14
期刊:
影响因子:
4.6
通讯作者:
Chen YA
Chen YA
中科院分区:
综合性期刊3区
文献类型:
--
作者:
Fang CC;Wu CF;Liao YJ;Huang SF;Chen M;Chen YA

文献摘要

参考文献

被引文献

相似文献

甘氨酸n -甲基转移酶(Glycine N-methyltransferase, GNMT)在正常肝脏中大量表达,对肿瘤的形成起保护作用。GNMT缺失导致肝细胞癌(HCC)的进展。在这项研究中,我们研究了重组腺相关病毒(AAV)基因治疗小鼠肝硬化和HCC模型的异位GNMT的活性。在GNMT - / -小鼠中注射携带GNMT基因(AAV8-GNMT)的AAV血清型8 (AAV8)载体,增加GNMT的表达,下调促炎反应,减少肝损伤和肝脏肿瘤的发生率。此外,AAV8-GNMT可改善四氯化碳(CCl4)诱导的BALB/c小鼠肝纤维化。我们发现AAV8-GNMT保护肝细胞免受ccl4诱导的肝损伤。AAV8-GNMT显著降低促纤维化标志物水平,提高肝细胞增殖效率。这些结果表明,通过aav8介导的基因增强基因治疗来纠正肝脏GNMT可能为预防和延缓肝脏疾病的发展提供了一种潜在的策略。
Glycine N-methyltransferase (GNMT) is abundantly expressed in normal livers and plays a protective role against tumor formation. GNMT depletion leads to progression of hepatocellular carcinoma (HCC). In this study, we investigated the activity of ectopic GNMT delivered using recombinant adeno-associated virus (AAV) gene therapy in mouse models of liver cirrhosis and HCC. Injection of AAV serotype 8 (AAV8) vector carrying the GNMT gene (AAV8-GNMT) in Gnmt−/− mice increased GNMT expression and downregulated pro-inflammatory responses, resulting in reduced liver damage and incidence of liver tumors. Moreover, AAV8-GNMT resulted in the amelioration of carbon tetrachloride (CCl4)-induced liver fibrosis in BALB/c mice. We showed that AAV8-GNMT protected hepatocytes from CCl4-induced liver damage.  AAV8-GNMT significantly attenuated the levels of pro-fibrotic markers and increased efficiency of hepatocyte proliferation. These results suggest that correction of hepatic GNMT by gene therapy of AAV8-mediated gene enhancement may provide a potential strategy for preventing and delaying development of liver diseases.
DOI: 10.1007/978-3-0348-0837-8_16
发表时间: 2014-01-01
期刊: INFLAMMATION AND CANCER
影响因子: --
作者:
Bishayee, Anupam
通讯作者: Bishayee, Anupam
DOI: 10.1016/j.ymgme.2011.06.002
发表时间: 2011-11-01
影响因子: 3.8
作者:
Bell, Peter;Wang, Lili;Wilson, James M.
通讯作者: Wilson, James M.
DOI: 10.1002/hep.21863
发表时间: 2007-11-01
期刊: HEPATOLOGY
影响因子: 13.5
作者:
Liu, Shih-Ping;Li, Ying-Shiuan;Chen, Yi-Ming Arthur
通讯作者: Chen, Yi-Ming Arthur
DOI: 10.7150/ijbs.22235
发表时间: 2018
影响因子: 9.2
作者:
Mao Y;Pei N;Chen X;Chen H;Yan R;Bai N;Li A;Li J;Zhang Y;Du H;Chen B;Sumners C;Wang X;Wang S;Li H
通讯作者: Li H
DOI: 10.1038/nm.2490
发表时间: 2011-11-27
期刊: Nature medicine
影响因子: 82.9
作者:
通讯作者: --